Literature DB >> 17663188

Determination of olmesartan medoxomil in tablets by UV-Vis spectrophotometry.

M Celebier1, S Altinoz.   

Abstract

A simple, rapid and reliable UV spectrophotometric method was developed for the determination of olmesartan medoxomil in pharmaceutical dosage forms. The solutions of standard, tablet and synthetic tablet were prepared in acetonitrile and in NaOH-Water. 258 nm and 250 nm were chosen for acetonitrile and for NaOH-Water solutions respectively. The developed method was validated with respect to stability, linearity, sensitivity, specificity, precision, accuracy, robustness and ruggedness. The linearity range of the method was 1.0-70.0 microg x mL(-1) for acetonitrile solutions and 1.0-75.0 microg x mL(-1) for NaOH-Water solutions. The developed and validated method was applied for the determination of olmesartan medoxomil in pharmaceutical dosage forms.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17663188

Source DB:  PubMed          Journal:  Pharmazie        ISSN: 0031-7144            Impact factor:   1.267


  4 in total

1.  Multivariate versus classical univariate calibration methods for spectrofluorimetric data: application to simultaneous determination of olmesartan medoxamil and amlodipine besylate in their combined dosage form.

Authors:  Hany W Darwish; Ahmed H Backeit
Journal:  J Fluoresc       Date:  2012-08-16       Impact factor: 2.217

2.  Development of a novel 96-microwell assay with high throughput for determination of olmesartan medoxomil in its tablets.

Authors:  Ibrahim A Darwish; Tanveer A Wani; Nasr Y Khalil; Abdul-Aziz Al-Shaikh; Najm Al-Morshadi
Journal:  Chem Cent J       Date:  2012-01-03       Impact factor: 4.215

3.  Application of a Stability-Indicating HPTLC Method for Simultaneous Quantitative Determination of Olmesartan Medoxomil and Hydrochlorothiazide in Pharmaceutical Dosage Forms.

Authors:  Kaliappan Ilango; Pushpangadhan S Shiji Kumar
Journal:  J Anal Methods Chem       Date:  2013-11-04       Impact factor: 2.193

4.  Controlled release of pharmaceutical agents using eutectic modified gelatin.

Authors:  Wanwan Qu; Idrees B Qader; Andrew P Abbott
Journal:  Drug Deliv Transl Res       Date:  2021-05-08       Impact factor: 4.617

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.